-
1
-
-
0032932825
-
Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations
-
Greig NH, Holloway HW, De Ore KA, Jani D, Wang Y, Zhou J, Garant MJ, Egan JM. Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations. Diabetologia. 1999;42:45-50.
-
(1999)
Diabetologia.
, vol.42
, pp. 45-50
-
-
Greig, N.H.1
Holloway, H.W.2
De Ore, K.A.3
Jani, D.4
Wang, Y.5
Zhou, J.6
Garant, M.J.7
Egan, J.M.8
-
2
-
-
0038497464
-
Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
-
Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2003;88:3082-3089.
-
(2003)
J Clin Endocrinol Metab.
, vol.88
, pp. 3082-3089
-
-
Kolterman, O.G.1
Buse, J.B.2
Fineman, M.S.3
Gaines, E.4
Heintz, S.5
Bicsak, T.A.6
Taylor, K.7
Kim, D.8
Aisporna, M.9
Wang, Y.10
Baron, A.D.11
-
3
-
-
0035340019
-
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro
-
Parkes DG, Pittner R, Jodka C, Smith P, Young A. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism. 2001;50:583-589.
-
(2001)
Metabolism.
, vol.50
, pp. 583-589
-
-
Parkes, D.G.1
Pittner, R.2
Jodka, C.3
Smith, P.4
Young, A.5
-
4
-
-
3242664057
-
Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes
-
Dupre J, Behme MT, McDonald TJ. Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes. J Clin Endocrinol Metab. 2004;89:3469-3473.
-
(2004)
J Clin Endocrinol Metab.
, vol.89
, pp. 3469-3473
-
-
Dupre, J.1
Behme, M.T.2
McDonald, T.J.3
-
5
-
-
0034456212
-
Exendin-4 decelerates food intake weight gain and fat deposition in zucker rats
-
Szayna M, Doyle ME, Betkey JA, HollowayHW,Spencer RG, Greig NH, Egan JM. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology. 2000;141:1936-1941.
-
(2000)
Endocrinology.
, vol.141
, pp. 1936-1941
-
-
Szayna, M.1
Doyle, M.E.2
Betkey, J.A.3
Holloway, H.W.4
Spencer, R.G.5
Greig, N.H.6
Egan, J.M.7
-
6
-
-
0033513455
-
Exendin-4 stimulates both α-cell replication and neogenesis, resulting in increased α-cell mass and improved glucose tolerance in diabetic rats
-
Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both α-cell replication and neogenesis, resulting in increased α-cell mass and improved glucose tolerance in diabetic rats. Diabetes. 1999;48:2270-2276.
-
(1999)
Diabetes.
, vol.48
, pp. 2270-2276
-
-
Xu, G.1
Stoffers, D.A.2
Habener, J.F.3
Bonner-Weir, S.4
-
7
-
-
52749096469
-
Exendin-4 stimulation of cyclin A2 in α-cell proliferation
-
Song WJ, SchreiberWE,Zhong E, Liu FF, Kornfeld BD, Wondisford FE, Hussain MA. Exendin-4 stimulation of cyclin A2 in α-cell proliferation. Diabetes. 2008;57:2371-2381.
-
(2008)
Diabetes.
, vol.57
, pp. 2371-2381
-
-
Song, W.J.1
Schreiber, W.E.2
Zhong, E.3
Liu, F.F.4
Kornfeld, B.D.5
Wondisford, F.E.6
Hussain, M.A.7
-
8
-
-
48449104756
-
Exendin-4 protects β-cells from interleukin-1 α-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway
-
Ferdaoussi M, Abdelli S, Yang JY, Cornu M, Niederhauser G, Favre D, Widmann C, Regazzi R, Thorens B, Waeber G, Abderrahmani A. Exendin-4 protects β-cells from interleukin-1 α-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes. 2008;57:1205-1215.
-
(2008)
Diabetes.
, vol.57
, pp. 1205-1215
-
-
Ferdaoussi, M.1
Abdelli, S.2
Yang, J.Y.3
Cornu, M.4
Niederhauser, G.5
Favre, D.6
Widmann, C.7
Regazzi, R.8
Thorens, B.9
Waeber, G.10
Abderrahmani, A.11
-
9
-
-
17144404555
-
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
-
Gorrell MD. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci (Lond). 2005;108:277-292.
-
(2005)
Clin Sci (Lond).
, vol.108
, pp. 277-292
-
-
Gorrell, M.D.1
-
10
-
-
0035723325
-
CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes
-
Gorrell MD, Gysbers V, McCaughan GW. CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol. 2001;54:249-264.
-
(2001)
Scand J Immunol.
, vol.54
, pp. 249-264
-
-
Gorrell, M.D.1
Gysbers, V.2
McCaughan, G.W.3
-
11
-
-
44549085494
-
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
-
Ohnuma K, Dang NH, Morimoto C. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol. 2008;29:295-301.
-
(2008)
Trends Immunol.
, vol.29
, pp. 295-301
-
-
Ohnuma, K.1
Dang, N.H.2
Morimoto, C.3
-
12
-
-
76349097770
-
The dipeptidyl peptidase IV family in cancer and cell biology
-
Yu DM, Yao TW, Chowdhury S, Nadvi NA, Osborne B, Church WB, McCaughan GW, Gorrell MD. The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J. 2010;277:1126-1144.
-
(2010)
FEBS J.
, vol.277
, pp. 1126-1144
-
-
Yu, D.M.1
Yao, T.W.2
Chowdhury, S.3
Nadvi, N.A.4
Osborne, B.5
Church, W.B.6
McCaughan, G.W.7
Gorrell, M.D.8
-
13
-
-
78650799604
-
Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding
-
Yu DM, Slaitini L, Gysbers V, Riekhoff AG, Kahne T, Knott HM, De Meester I, Abbott CA, McCaughan GW, Gorrell MD. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding. Scand J Immunol. 2011; 73:102-111.
-
(2011)
Scand J Immunol.
, vol.73
, pp. 102-111
-
-
Yu, D.M.1
Slaitini, L.2
Gysbers, V.3
Riekhoff, A.G.4
Kahne, T.5
Knott, H.M.6
De Meester, I.7
Abbott, C.A.8
McCaughan, G.W.9
Gorrell, M.D.10
-
14
-
-
0037787851
-
Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties functions and clinical aspects of the enzyme DPP IV 2003
-
Lambeir AM, Durinx C, Scharpe S, De Meester I. Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV 2003. Crit Rev Clin Lab Sci. 40:209-294.
-
Crit Rev Clin Lab Sci.
, vol.40
, pp. 209-294
-
-
Lambeir, A.M.1
Durinx, C.2
Scharpe, S.3
De Meester, I.4
-
15
-
-
80052096595
-
Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome
-
Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Muller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011;60:1917-1925.
-
(2011)
Diabetes.
, vol.60
, pp. 1917-1925
-
-
Lamers, D.1
Famulla, S.2
Wronkowitz, N.3
Hartwig, S.4
Lehr, S.5
Ouwens, D.M.6
Eckardt, K.7
Kaufman, J.M.8
Ryden, M.9
Muller, S.10
Hanisch, F.G.11
Ruige, J.12
Arner, P.13
Sell, H.14
Eckel, J.15
-
16
-
-
78649730402
-
DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediatedERKactivation and ERK-dependent MMP-1 expression by U937 histiocytes
-
Ta NN, Li Y, Schuyler CA, Lopes-Virella MF, Huang Y. DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediatedERKactivation and ERK-dependent MMP-1 expression by U937 histiocytes. Atherosclerosis. 2010;213:429-435.
-
(2010)
Atherosclerosis.
, vol.213
, pp. 429-435
-
-
Ta, N.N.1
Li, Y.2
Schuyler, C.A.3
Lopes-Virella, M.F.4
Huang, Y.5
-
17
-
-
81855222104
-
Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis
-
Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z, Xu X, Lu B, Moffatt-Bruce S, Durairaj R, Sun Q, Mihai G, Maiseyeu A, Rajagopalan S. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation. 2011;124:2338-2349.
-
(2011)
Circulation.
, vol.124
, pp. 2338-2349
-
-
Shah, Z.1
Kampfrath, T.2
Deiuliis, J.A.3
Zhong, J.4
Pineda, C.5
Ying, Z.6
Xu, X.7
Lu, B.8
Moffatt-Bruce, S.9
Durairaj, R.10
Sun, Q.11
Mihai, G.12
Maiseyeu, A.13
Rajagopalan, S.14
-
18
-
-
77958195997
-
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1β
-
Fadini GP, Boscaro E, Albiero M, Menegazzo L, Frison V, de Kreutzenberg S, Agostini C, Tiengo A, Avogaro A. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1β. Diabetes Care. 2010;33:1607-1609.
-
(2010)
Diabetes Care.
, vol.33
, pp. 1607-1609
-
-
Fadini, G.P.1
Boscaro, E.2
Albiero, M.3
Menegazzo, L.4
Frison, V.5
De Kreutzenberg, S.6
Agostini, C.7
Tiengo, A.8
Avogaro, A.9
-
19
-
-
77952100841
-
Impact of insulin resistance on enhanced monocyte adhesion to endothelial cells and atherosclerogenesis independent of LDL cholesterol level
-
Mita T, Goto H,AzumaK, JinWL,Nomiyama T, Fujitani Y, Hirose T, Kawamori R, Watada H. Impact of insulin resistance on enhanced monocyte adhesion to endothelial cells and atherosclerogenesis independent of LDL cholesterol level. Biochem Biophys Res Commun. 2010;395:477-483.
-
(2010)
Biochem Biophys Res Commun.
, vol.395
, pp. 477-483
-
-
Mita, T.1
Goto, H.2
Azuma, K.3
Jin, W.L.4
Nomiyama, T.5
Fujitani, Y.6
Hirose, T.7
Kawamori, R.8
Watada, H.9
-
20
-
-
77951151612
-
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4
-
Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T, Fujitani Y, Hirose T, Kawamori R, Watada H. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes. 2010;59:1030-1037.
-
(2010)
Diabetes.
, vol.59
, pp. 1030-1037
-
-
Arakawa, M.1
Mita, T.2
Azuma, K.3
Ebato, C.4
Goto, H.5
Nomiyama, T.6
Fujitani, Y.7
Hirose, T.8
Kawamori, R.9
Watada, H.10
-
21
-
-
0042889298
-
A new En face method is useful to quantitate endothelial damage in vivo
-
Azuma K, Watada H, Niihashi M, Otsuka A, Sato F, Kawasumi M, Shimada S, Tanaka Y, Kawamori R, Mitsumata M. A new En face method is useful to quantitate endothelial damage in vivo. Biochem Biophys Res Commun. 2003;309:384-390.
-
(2003)
Biochem Biophys Res Commun.
, vol.309
, pp. 384-390
-
-
Azuma, K.1
Watada, H.2
Niihashi, M.3
Otsuka, A.4
Sato, F.5
Kawasumi, M.6
Shimada, S.7
Tanaka, Y.8
Kawamori, R.9
Mitsumata, M.10
-
22
-
-
34249063553
-
Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice
-
Mita T, Otsuka A, Azuma K, Uchida T, Ogihara T, Fujitani Y, Hirose T, Mitsumata M, Kawamori R, Watada H. Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2007;358:679-685.
-
(2007)
Biochem Biophys Res Commun.
, vol.358
, pp. 679-685
-
-
Mita, T.1
Otsuka, A.2
Azuma, K.3
Uchida, T.4
Ogihara, T.5
Fujitani, Y.6
Hirose, T.7
Mitsumata, M.8
Kawamori, R.9
Watada, H.10
-
23
-
-
57549112337
-
In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid
-
Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, Azuma K, Itoh M, Yamamoto Y, Kamei Y, Horie M, Watada H, Ogawa Y. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 2008;28:2173-2179.
-
(2008)
Arterioscler Thromb Vasc Biol.
, vol.28
, pp. 2173-2179
-
-
Yamada, H.1
Yoshida, M.2
Nakano, Y.3
Suganami, T.4
Satoh, N.5
Mita, T.6
Azuma, K.7
Itoh, M.8
Yamamoto, Y.9
Kamei, Y.10
Horie, M.11
Watada, H.12
Ogawa, Y.13
-
24
-
-
48049089641
-
The effects of flap ischemia on normal and diabetic progenitor cell function
-
Tanaka R, Wada M, Kwon SM, Masuda H, Carr J, Ito R, Miyasaka M,Warren SM, Asahara T, TepperOM.The effects of flap ischemia on normal and diabetic progenitor cell function. Plast Reconstr Surg. 2008;121:1929-1942.
-
(2008)
Plast Reconstr Surg.
, vol.121
, pp. 1929-1942
-
-
Tanaka, R.1
Wada, M.2
Kwon, S.M.3
Masuda, H.4
Carr, J.5
Ito, R.6
Miyasaka, M.7
Warren, S.M.8
Asahara, T.9
Tepper, O.M.10
-
25
-
-
42149107512
-
Role of smooth muscle cells in the initiation and early progression of atherosclerosis
-
Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:812-819.
-
(2008)
Arterioscler Thromb Vasc Biol.
, vol.28
, pp. 812-819
-
-
Doran, A.C.1
Meller, N.2
McNamara, C.A.3
-
26
-
-
34547209343
-
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
-
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2007;1773: 1263-1284.
-
(2007)
Biochim Biophys Acta.
, vol.1773
, pp. 1263-1284
-
-
McCubrey, J.A.1
Steelman, L.S.2
Chappell, W.H.3
Abrams, S.L.4
Wong, E.W.5
Chang, F.6
Lehmann, B.7
Terrian, D.M.8
Milella, M.9
Tafuri, A.10
Stivala, F.11
Libra, M.12
Basecke, J.13
Evangelisti, C.14
Martelli, A.M.15
Franklin, R.A.16
-
27
-
-
0031606916
-
Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors
-
Dubey RK, Gillespie DG, Mi Z. Jackson EK: Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors. Hypertension. 1998;31:516-521.
-
(1998)
Hypertension.
, vol.31
, pp. 516-521
-
-
Dubey, R.K.1
Gillespie, D.G.2
Mi, Z.3
Jackson, E.K.4
-
28
-
-
84858693780
-
Regulation of macrophage function by adenosine
-
Hasko G, Pacher P. Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol. 2012;32:865-869.
-
(2012)
Arterioscler Thromb Vasc Biol.
, vol.32
, pp. 865-869
-
-
Hasko, G.1
Pacher, P.2
-
30
-
-
18244424507
-
Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice
-
Xu Q, Zhang Z, Davison F, Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res. 2003;93:e76-86.
-
(2003)
Circ Res.
, vol.93
-
-
Xu, Q.1
Zhang, Z.2
Davison, F.3
Hu, Y.4
-
31
-
-
34247117818
-
Endothelial progenitor cells in health and atherosclerotic disease
-
Werner N, Nickenig G. Endothelial progenitor cells in health and atherosclerotic disease. Ann Med. 2007;39:82-90.
-
(2007)
Ann Med.
, vol.39
, pp. 82-90
-
-
Werner, N.1
Nickenig, G.2
-
32
-
-
79551488587
-
Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury
-
Goto H, Nomiyama T, Mita T, Yasunari E, Azuma K, Komiya K, Arakawa M, Jin WL, Kanazawa A, Kawamori R, Fujitani Y, Hirose T, Watada H. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury. Biochem Biophys Res Commun. 2011;405:79-84.
-
(2011)
Biochem Biophys Res Commun.
, vol.405
, pp. 79-84
-
-
Goto, H.1
Nomiyama, T.2
Mita, T.3
Yasunari, E.4
Azuma, K.5
Komiya, K.6
Arakawa, M.7
Jin, W.L.8
Kanazawa, A.9
Kawamori, R.10
Fujitani, Y.11
Hirose, T.12
Watada, H.13
-
33
-
-
84862908699
-
A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein e-deficient mice
-
Matsubara J, Sugiyama S, Sugamura K, Nakamura T, Fujiwara Y, Akiyama E, Kurokawa H, Nozaki T, Ohba K, KonishiM,Maeda H, Izumiya Y, Kaikita K, Sumida H, Jinnouchi H, Matsui K, Kim-Mitsuyama S, Takeya M, Ogawa H. A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein e-deficient mice. J Am Coll Cardiol. 2012;59:265-276.
-
(2012)
J Am Coll Cardiol.
, vol.59
, pp. 265-276
-
-
Matsubara, J.1
Sugiyama, S.2
Sugamura, K.3
Nakamura, T.4
Fujiwara, Y.5
Akiyama, E.6
Kurokawa, H.7
Nozaki, T.8
Ohba, K.9
Konishi, M.10
Maeda, H.11
Izumiya, Y.12
Kaikita, K.13
Sumida, H.14
Jinnouchi, H.15
Matsui, K.16
Kim-Mitsuyama, S.17
Takeya, M.18
Ogawa, H.19
-
34
-
-
77949273334
-
The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
-
Hsieh J, Longuet C, Baker CL, Qin B, Federico LM, Drucker DJ, Adeli K. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. Diabetologia. 2010;53:552-561.
-
(2010)
Diabetologia.
, vol.53
, pp. 552-561
-
-
Hsieh, J.1
Longuet, C.2
Baker, C.L.3
Qin, B.4
Federico, L.M.5
Drucker, D.J.6
Adeli, K.7
-
35
-
-
84861844675
-
Sitagliptin promotes macrophage-to-faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP-apoB100 transgenic mice
-
Briand F, Thieblemont Q, Burcelin R, Sulpice T. Sitagliptin promotes macrophage-to-faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP-apoB100 transgenic mice. Diabetes Obes Metab. 2012;14: 662-665.
-
(2012)
Diabetes Obes Metab.
, vol.14
, pp. 662-665
-
-
Briand, F.1
Thieblemont, Q.2
Burcelin, R.3
Sulpice, T.4
-
36
-
-
0033852128
-
Molecular characterization of dipeptidyl peptidase activity in serum: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides
-
Durinx C, Lambeir AM, Bosmans E, Falmagne JB, Berghmans R, Haemers A, Scharpe S, De Meester I. Molecular characterization of dipeptidyl peptidase activity in serum: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem. 2000;267:5608-5613.
-
(2000)
Eur J Biochem.
, vol.267
, pp. 5608-5613
-
-
Durinx, C.1
Lambeir, A.M.2
Bosmans, E.3
Falmagne, J.B.4
Berghmans, R.5
Haemers, A.6
Scharpe, S.7
De Meester, I.8
-
38
-
-
0028790702
-
Expression of ectoadenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule
-
Martin M, Huguet J, Centelles JJ, Franco R. Expression of ectoadenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol. 1995;155:4630-4643.
-
(1995)
J Immunol.
, vol.155
, pp. 4630-4643
-
-
Martin, M.1
Huguet, J.2
Centelles, J.J.3
Franco, R.4
-
39
-
-
0031573556
-
Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation
-
DongRP, Tachibana K, HegenM,Munakata Y,ChoD, Schlossman SF, Morimoto C. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. J Immunol. 1997;159:6070-6076.
-
(1997)
J Immunol.
, vol.159
, pp. 6070-6076
-
-
Dong, R.P.1
Tachibana, K.2
Hegen, M.3
Munakata, Y.4
Cho, D.5
Schlossman, S.F.6
Morimoto, C.7
-
40
-
-
8044233036
-
Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase
-
Hegen M, Kameoka J, Dong RP, Schlossman SF, Morimoto C. Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology. 1997;90:257-264.
-
(1997)
Immunology.
, vol.90
, pp. 257-264
-
-
Hegen, M.1
Kameoka, J.2
Dong, R.P.3
Schlossman, S.F.4
Morimoto, C.5
-
41
-
-
0000038304
-
Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted β propeller domain
-
Abbott CA, McCaughan GW, Levy MT, Church WB, Gorrell MD. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted β propeller domain. Eur J Biochem. 1999;266:798-810.
-
(1999)
Eur J Biochem.
, vol.266
, pp. 798-810
-
-
Abbott, C.A.1
McCaughan, G.W.2
Levy, M.T.3
Church, W.B.4
Gorrell, M.D.5
-
42
-
-
0029133321
-
Costimulation of CD4-and CD8+ T cells through CD26: The ADA-binding epitope is not essential for complete signaling
-
De Meester IA, Kestens LL, Vanham GL, Vanhoof GC, Vingerhoets JH, Gigase PL, Scharpe SL. Costimulation of CD4-and CD8+ T cells through CD26: The ADA-binding epitope is not essential for complete signaling. J Leukoc Biol. 1995;58:325-330.
-
(1995)
J Leukoc Biol.
, vol.58
, pp. 325-330
-
-
De Meester, I.A.1
Kestens, L.L.2
Vanham, G.L.3
Vanhoof, G.C.4
Vingerhoets, J.H.5
Gigase, P.L.6
Scharpe, S.L.7
-
43
-
-
0033552883
-
Atherosclerosis-an inflammatory disease
-
Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
-
(1999)
N Engl J Med.
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
44
-
-
8344275053
-
Inhibition of tumor necrosis factor-β reduces atherosclerosis in apolipoprotein E knockout mice
-
Branen L, Hovgaard L, NitulescuM,Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-β reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:2137-2142.
-
(2004)
Arterioscler Thromb Vasc Biol.
, vol.24
, pp. 2137-2142
-
-
Branen, L.1
Hovgaard, L.2
Nitulescu, M.3
Bengtsson, E.4
Nilsson, J.5
Jovinge, S.6
-
45
-
-
62949195390
-
Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction
-
ZarubaMM,Theiss HD, Vallaster M, Mehl U, Brunner S, David R, Fischer R, Krieg L, Hirsch E, Huber B, Nathan P, Israel L, Imhof A, Herbach N, Assmann G, Wanke R, Mueller-Hoecker J, Steinbeck G, Franz WM. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell. 2009;4:313-323.
-
(2009)
Cell Stem Cell.
, vol.4
, pp. 313-323
-
-
Zaruba, M.M.1
Theiss, H.D.2
Vallaster, M.3
Mehl, U.4
Brunner, S.5
David, R.6
Fischer, R.7
Krieg, L.8
Hirsch, E.9
Huber, B.10
Nathan, P.11
Israel, L.12
Imhof, A.13
Herbach, N.14
Assmann, G.15
Wanke, R.16
Mueller-Hoecker, J.17
Steinbeck, G.18
Franz, W.M.19
-
46
-
-
79952012074
-
The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development
-
Briasoulis A, Tousoulis D, Antoniades C, Stefanadis C, Papageorgiou N. The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovasc Ther. 2010;29:125-139.
-
(2010)
Cardiovasc Ther.
, vol.29
, pp. 125-139
-
-
Briasoulis, A.1
Tousoulis, D.2
Antoniades, C.3
Stefanadis, C.4
Papageorgiou, N.5
-
47
-
-
80655146931
-
Discovery And Pharmacological Characterization Of N-[2-({2-[(2S)-2- cyanopyrrolidin-1-yl]-2-Oxoethyl}amino)-2-methylpropyl]-2-methyl Pyrazolo [1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor]
-
Kato N, Oka M, Murase T, Yoshida M, Sakairi M, Yamashita S, Yasuda Y, Yoshikawa A, Hayashi Y, Makino M, Takeda M, Mirensha Y, Kakigami T. Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]- 2-oxoethyl}amino)-2-methylpropyl]-2-methyl pyrazolo[1,5-a]pyrimidine-6- carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor. Bioorg Med Chem. 2011;19:7221-7227.
-
(2011)
Bioorg Med Chem.
, vol.19
, pp. 7221-7227
-
-
Kato, N.1
Oka, M.2
Murase, T.3
Yoshida, M.4
Sakairi, M.5
Yamashita, S.6
Yasuda, Y.7
Yoshikawa, A.8
Hayashi, Y.9
Makino, M.10
Takeda, M.11
Mirensha, Y.12
Kakigami, T.13
-
48
-
-
25844459084
-
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: Potential importance of selectivity over dipeptidyl peptidases 8 and 9
-
Lankas GR, Leiting B, Roy RS, Eiermann GJ, Beconi MG, Biftu T, Chan CC, Edmondson S, Feeney WP, He H, Ippolito DE, Kim D, Lyons KA, Ok HO, Patel RA, Petrov AN, Pryor KA, Qian X, Reigle L, Woods A, Wu JK, Zaller D, Zhang X, Zhu L, Weber AE, Thornberry NA. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: Potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes. 2005;54:2988-2994.
-
(2005)
Diabetes.
, vol.54
, pp. 2988-2994
-
-
Lankas, G.R.1
Leiting, B.2
Roy, R.S.3
Eiermann, G.J.4
Beconi, M.G.5
Biftu, T.6
Chan, C.C.7
Edmondson, S.8
Feeney, W.P.9
He, H.10
Ippolito, D.E.11
Kim, D.12
Lyons, K.A.13
Ok, H.O.14
Patel, R.A.15
Petrov, A.N.16
Pryor, K.A.17
Qian, X.18
Reigle, L.19
Woods, A.20
Wu, J.K.21
Zaller, D.22
Zhang, X.23
Zhu, L.24
Weber, A.E.25
Thornberry, N.A.26
more..
-
49
-
-
79960661852
-
A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling
-
YaoTW,KimWS,YuDM,Sharbeen G,McCaughanGW,ChoiKY, Xia P, Gorrell MD. A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling. Mol Cancer Res. 2011;9:948-959.
-
(2011)
Mol Cancer Res.
, vol.9
, pp. 948-959
-
-
Yao, T.W.1
Kim, W.S.2
Yu, D.M.3
Sharbeen, G.4
McCaughanG, W.5
Choi, K.Y.6
Xia, P.7
Gorrell, M.D.8
-
50
-
-
33646706075
-
Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis
-
YuDM,WangXM,McCaughanGW,GorrellMD.Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J. 2006;273: 2447-2460.
-
(2006)
FEBS J.
, vol.273
, pp. 2447-2460
-
-
Yu, D.M.1
Wang, X.M.2
McCaughan, G.W.3
Gorrell, M.D.4
|